Hasil Pencarian - Max Stanley Chartrand

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

    Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders oleh Alexander Markov, Lakshmi Thangavelu, Surendar Aravindhan, Angelina Olegovna Zekiy, Mostafa Jarahian, Max Stanley Chartrand, Yashwant Pathak, Faroogh Marofi, Somayeh Shamlou, Ali Hassanzadeh

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

    RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders oleh Alexander Markov, Lakshmi Thangavelu, Surendar Aravindhan, Angelina Olegovna Zekiy, Mostafa Jarahian, Max Stanley Chartrand, Yashwant Pathak, Faroogh Marofi, Somayeh Shamlou, Ali Hassanzadeh

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities

    Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities oleh Ali Hassanzadeh, Heshu Sulaiman Rahman, Alexander Markov, Judi Januadi Endjun, Angelina Olegovna Zekiy, Max Stanley Chartrand, Nasrin Beheshtkhoo, Mohammad Amin Jadidi Kouhbanani, Faroogh Marofi, Marzieh Nikoo, Mostafa Jarahian

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

    Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism oleh Faroogh Marofi, Safa Tahmasebi, Heshu Sulaiman Rahman, Denis Kaigorodov, Alexander Markov, Alexei Valerievich Yumashev, Navid Shomali, Max Stanley Chartrand, Yashwant Pathak, Rebar N. Mohammed, Mostafa Jarahian, Roza Motavalli, Farhad Motavalli Khiavi

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

    Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism oleh Faroogh Marofi, Safa Tahmasebi, Heshu Sulaiman Rahman, Denis Kaigorodov, Alexander Markov, Alexei Valerievich Yumashev, Navid Shomali, Max Stanley Chartrand, Yashwant Pathak, Rebar N. Mohammed, Mostafa Jarahian, Roza Motavalli, Farhad Motavalli Khiavi

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy

    Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy oleh Faroogh Marofi, Heshu Sulaiman Rahman, Lakshmi Thangavelu, Aleksey Dorofeev, Favian Bayas-Morejón, Naghmeh Shirafkan, Navid Shomali, Max Stanley Chartrand, Mostafa Jarahian, Ghasem Vahedi, Rebar N. Mohammed, Somayeh Shahrokh, Morteza Akbari, Farhad Motavalli Khiavi

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    CAR T cells in solid tumors: challenges and opportunities

    CAR T cells in solid tumors: challenges and opportunities oleh Faroogh Marofi, Roza Motavalli, Vladimir A. Safonov, Lakshmi Thangavelu, Alexei Valerievich Yumashev, Markov Alexander, Navid Shomali, Max Stanley Chartrand, Yashwant Pathak, Mostafa Jarahian, Sepideh Izadi, Ali Hassanzadeh, Naghmeh Shirafkan, Safa Tahmasebi, Farhad Motavalli Khiavi

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    RETRACTED: CAR-NK Cell: A New Paradigm in Tumor Immunotherapy

    RETRACTED: CAR-NK Cell: A New Paradigm in Tumor Immunotherapy oleh Faroogh Marofi, Alaa S. Al-Awad, Heshu Sulaiman Rahman, Heshu Sulaiman Rahman, Alexander Markov, Alexander Markov, Walid Kamal Abdelbasset, Walid Kamal Abdelbasset, Yulianna Ivanovna Enina, Mahnaz Mahmoodi, Ali Hassanzadeh, Mahboubeh Yazdanifar, Max Stanley Chartrand, Mostafa Jarahian

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    RETRACTED: Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy

    RETRACTED: Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy oleh Ali Hassanzadeh, Amjad Hussein Altajer, Heshu Sulaiman Rahman, Heshu Sulaiman Rahman, Marwan Mahmood Saleh, Dmitry O. Bokov, Walid Kamal Abdelbasset, Walid Kamal Abdelbasset, Faroogh Marofi, Majid Zamani, Yoda Yaghoubi, Mahboubeh Yazdanifar, Yashwant Pathak, Yashwant Pathak, Max Stanley Chartrand, Mostafa Jarahian

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients

    Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients oleh Faroogh Marofi, Heshu Sulaiman Rahman, Zaid Mahdi Jaber Al-Obaidi, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Wanich Suksatan, Aleksei Evgenievich Dorofeev, Navid Shomali, Max Stanley Chartrand, Yashwant Pathak, Ali Hassanzadeh, Behzad Baradaran, Majid Ahmadi, Hossein Saeedi, Safa Tahmasebi, Mostafa Jarahian

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: